Katie Rae Crawford, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 1176 State Highway 22 W Ste B, Dardanelle, AR 72834 Phone: 479-229-3004 Fax: 870-994-7488 |
Christa Bartlett, Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 1652 State Highway 22 W, Dardanelle, AR 72834 Phone: 479-229-8000 Fax: 479-477-3925 |
Concetta Whitley Martin, PA Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 1652 State Highway 22 W, Dardanelle, AR 72834 Phone: 479-229-8000 Fax: 479-477-3925 |
Susan Rebekah Stuck, Physician Assistant Medicare: Medicare Enrolled Practice Location: 1652 State Highway 22 W, Dardanelle, AR 72834 Phone: 479-229-8000 Fax: 479-477-3925 |
News Archive
Our immune systems are in a constant battle with foreign invaders to keep our bodies healthy. Outside forces like pollution, poor nutrition and new strains of disease keep our immune systems at an overly boosted or inflamed state, which affects energy levels, body and emotional health and overall quality of life. Through inflammatory immune cells, our bodies fight to defend us from this onslaught. Too few of these cells can result in illness, while too many could lead to a high immune response, resulting in heightened inflammation and collateral damage to the body's once-healthy tissues.
In a paper recently uploaded to the preprint server medRxiv* by Sachak-Patwa et al. (May 22nd, 2021), mathematical models are developed to assess the probability and impact of such localized outbreaks, accounting for changing general immunity levels in the population as vaccines are distributed.
Speaking at a press conference on Thursday marking the International Day of Zero Tolerance to Female Genital Mutilation, recognized on February 6, U.S. Secretary of State Hillary Rodham Clinton "said ... that there is no cultural justification for female genital cutting, a practice that is sometimes referred to as female circumcision," and that "governments and non-governmental organizations are making progress toward ending female genital mutilation, or FGM, by reaching out to those who still practice it," VOA News reports.
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib has been granted orphan drug status for the treatment of patients with gastrointestinal stromal tumors by the U.S. Food and Drug Administration.
True benefit from healthcare products requires an unrelenting focus on patient- and consumer-centered safety, a principle that is at the heart of J&J's Credo and is embodied in the mission of the Office of the Chief Medical Officer (OCMO).
› Verified 9 days ago